← Back to the catalogue
Nucleotides and NAD pathway
Oxypurinol
Active metabolite of allopurinol, a drug that inhibits xanthine oxidase; its presence reflects exposure to this treatment.
Application contexts
- Cardiometabolic health
Matrices
- Tissues · liver
Related techniques
- ¹H-NMR
Related publications
- Remodeling of skeletal muscle myosin metabolic states in hibernating mammals. 2024 · eLife · 11 citations · Panel: NMR low-molecular-weight metabolites
- Remodelling of Skeletal Muscle Myosin Metabolic States in Hibernating Mammals. 2024 · bioRxiv : the preprint server for biology · 6 citations · Panel: NMR low-molecular-weight metabolites
- Initiating Empagliflozin and Sacubitril/Valsartan Early After Acute Myocardial Infarction: Mechanistic Study. 2025 · Journal of the American Heart Association · 1 citation · Panel: NMR low-molecular-weight metabolites
Show 1 more Show less
- Effect of early initiation of empagliflozin with or without sacubitril/valsartan in a swine model of myocardial infarction 2025 · British Journal of Surgery · Panel: NMR low-molecular-weight metabolites
Related news
- NMR Metabolomics in Animal Models: A Key Tool for Translational Research 10 April 2025 · Panel: NMR low-molecular-weight metabolites
- Desvelando Misterios de la Complejidad Lipoproteica en Diabetes Tipo 2 y Riesgo Cardiovascular 29 April 2024 · in Spanish · Panel: NMR low-molecular-weight metabolites
- Biosfer Teslab at the forefront of NMR sample analysis 26 March 2024 · Panel: NMR low-molecular-weight metabolites
Show 2 more Show less
- Exploring Metabolomics through Nuclear Magnetic Resonance and its Impact on Nutritional Interventions 13 February 2024 · Panel: NMR low-molecular-weight metabolites
- The Importance of Branched-Chain Amino Acids (BCAAs) in Metabolism Monitoring 08 February 2024 · Panel: NMR low-molecular-weight metabolites
Related projects
- COST Action AtheroNET 2022 · Consortium partner · Panel: NMR low-molecular-weight metabolites